Dataset Information


Combined serum levels of multiple proteins in tPA-BDNF pathway may aid the diagnosis of five mental disorders.

ABSTRACT: Mental disorders are severe, disabling conditions with unknown etiology and are commonly misdiagnosed when clinical symptomology criteria are solely used. Our previous work indicated that combination of serum levels of multiple proteins in tissue plasminogen activator (tPA)-brain-derived neurotrophic factor (BDNF) pathway improved accuracy of diagnosis of major depressive disorder (MDD). Here, we measured serum levels of tPA, plasminogen activator inhibitor-1 (PAI-1), BDNF, precursor-BDNF (proBDNF), tropomyosin-related kinase B (TrkB) and neurotrophin receptor p75 (p75NTR) in patients with paranoid schizophrenia (SZ, n?=?34), MDD (n?=?30), bipolar mania (BM, n?=?30), bipolar depression (BD, n?=?22), panic disorder (PD, n?=?30), and healthy controls (HCs, n?=?30) by Enzyme-linked immunosorbent assay kits. We used receiver operating characteristic (ROC) curve to analyze diagnostic potential of these proteins. We found, compared with HCs, that serum tPA and proBDNF were lower in SZ, BM and BD; TrkB was lower in SZ and BD; and p75NTR was declined in SZ and BM. ROC analysis showed that combined serum level of tPA, PAI-1, BDNF, proBDNF, TrkB and p75NTR was better than any single protein in accuracy of diagnosis and differentiation, suggesting that the combination of multiple serum proteins levels in tPA-BDNF pathway may have a potential for a diagnostic panel in mental disorders.

PROVIDER: S-EPMC5537244 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC5416686 | BioStudies
| S-EPMC8058084 | BioStudies
| S-EPMC6375841 | BioStudies
| S-EPMC5711538 | BioStudies
2010-01-01 | S-EPMC2987844 | BioStudies
| S-EPMC3465384 | BioStudies
| S-EPMC3338794 | BioStudies
2016-01-01 | S-EPMC5061880 | BioStudies
| S-EPMC8580986 | BioStudies
| S-EPMC6380376 | BioStudies